Tympanic Membrane Perforation Clinical Trial
— PERFOPEDOfficial title:
Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child
Verified date | December 2017 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is a retrospective cohort of patients minors during the operation of cartilage tympanoplasty for tympanic membrane perforation
Status | Completed |
Enrollment | 980 |
Est. completion date | December 8, 2017 |
Est. primary completion date | December 8, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Patient minors during the operation of cartilage tympanoplasty for tympanic membrane perforation (tympanoplasty for this first ear) - Patient operated between early 1998 and late 2012 - Postoperative audiometry and otoscopy available between 9 and 18 months after surgery Exclusion Criteria: - History of tympanoplasty ipsilateral, tympanic membrane perforation associated with épidermose or cholesteatoma - The holders of the parent or the patient has reached majority informed the doctor of their refusal to data collection. |
Country | Name | City | State |
---|---|---|---|
France | Hospital Necker - Enfants Malades | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | anatomical result of the appearance of the tympanoplasty (tympanic membrane perforation after surgery) | Closed eardrum Abnormal eardrum perforation residual, ear effusion, progressive retraction cholesteatoma |
12 months (range 9 to 18 months) | |
Secondary | Factors influencing the functional outcome of the tympanoplasty | mean bone conduction (BC) air conduction (AC) residual air-bone gap (RR = AC-BC). AC, BC and RR means are calculated on an average of four frequencies 0.5, 1, 2, 4 kHz Good functional outcome will be determined by an average RR =20 dB. A labyrinthisation be defined by a mean post-op compounded BC over 10 dB or moypostop BC - BC moypréop> 10 dB. |
12 months (range 9 to 18 months) | |
Secondary | Factors influencing the functional outcome of the tympanoplasty | mean bone conduction (BC) air conduction (AC) residual air-bone gap (RR = AC-BC). AC, BC and RR means are calculated on an average of four frequencies 0.5, 1, 2, 4 kHz Good functional outcome will be determined by an average RR =20 dB. A labyrinthisation be defined by a mean post-op compounded BC over 10 dB or moypostop BC - BC moypréop> 10 dB. |
36 months ( range 30 to 42 months) | |
Secondary | Change anatomical result of the tympanoplasty | 36 months ( range 30 to 42 months) | ||
Secondary | factors affecting the anatomical and functional results of the tympanoplasty. | clinical examination by pediatric ENT hearing test |
36 months ( range 30 to 42 months) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635228 -
Biodesign® Otologic Repair Graft
|
||
Active, not recruiting |
NCT00222417 -
Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05086718 -
Composite Cartilage Perichondrium Graft for Air Bone Gap Closure in Chronic Suppurative Otitis Media (CSOM) Without Posterior Meatal Flap
|
N/A | |
Withdrawn |
NCT03904316 -
Use of Biodesign® Otologic Graft in Tympanoplasty
|
Phase 4 | |
Completed |
NCT02307916 -
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
|
Phase 2 | |
Terminated |
NCT01766856 -
Eustachian Tube Function and Myringoplasty/Tympanoplasty
|
N/A | |
Recruiting |
NCT06260618 -
Effect of Chitodex Gel in Tympanoplasty Surgery
|
N/A | |
Recruiting |
NCT04960384 -
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
|
Phase 2 | |
Recruiting |
NCT03837665 -
Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06257602 -
Microscopic Versus Endoscopic Tympanoplasty
|
||
Completed |
NCT02550314 -
A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18
|
Phase 3 | |
Not yet recruiting |
NCT00310349 -
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease
|
Phase 3 | |
Not yet recruiting |
NCT03416725 -
Evaluation of Prognostic Factors in Tympanoplasty
|
N/A | |
Not yet recruiting |
NCT04428463 -
Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia
|
N/A | |
Completed |
NCT00714064 -
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers
|
Phase 3 | |
Completed |
NCT05605262 -
Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing.
|
Phase 2/Phase 3 | |
Recruiting |
NCT05849844 -
Tympanoseal Clinical Study
|
N/A | |
Not yet recruiting |
NCT04687995 -
Tragal Perichondrium Versus Pretragal Fascial (SMAS) Graft for Endoscopic Myringoplasty
|
N/A | |
Completed |
NCT02120651 -
Fibrin Monomer Compared With Hemostatic Sponge in the Integrity of the Graft During Tympanoplasty
|
Phase 3 | |
Withdrawn |
NCT03028272 -
Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft vs. Fascia for Tympanoplasty
|
N/A |